RK

Ranusmita Khuntia

Active Director Director DIN 10811820
DIN 10811820 First appointment Oct 2024 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Ranusmita Khuntia

Data last updated:

Ranusmita Khuntia is a Director at Tarinee Pharmaceuticals Private Limited (since 2024). The company operates in Research & Development.

DIN 10811820
Primary Designation Director
Industry Research & Development
First Appointment 17 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Oct 20242024Active

Board colleagues of Ranusmita Khuntia

NameDINCompanyDesignation
Jayaprakash Polei10811819Tarinee Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Tarinee Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ranusmita Khuntia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranusmita Khuntia

Ranusmita Khuntia currently holds 1 directorship: Tarinee Pharmaceuticals Private Limited (Director, since 17 Oct 2024).

Ranusmita Khuntia was first appointed on 17 Oct 2024 as Director at Tarinee Pharmaceuticals Private Limited.

The current boards of Ranusmita Khuntia's companies include Jayaprakash Polei (Tarinee Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available